IDRELIM Trademark

Trademark Overview

On Thursday, October 22, 2009, a trademark application was filed for IDRELIM with the United States Patent and Trademark Office. The USPTO has given the IDRELIM trademark a serial number of 77855172. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 6, 2014. This trademark is owned by Glaxo Group Limited. The IDRELIM trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines
idrelim

General Information

Serial Number77855172
Word MarkIDRELIM
Filing DateThursday, October 22, 2009
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 6, 2014
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 5, 2011

Trademark Statements

Goods and Servicespharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, October 27, 2009
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB6ONN
GB

Trademark Events

Event DateEvent Description
Monday, October 6, 2014ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, October 6, 2014ABANDONMENT - NO USE STATEMENT FILED
Friday, February 28, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 27, 2014EXTENSION 5 GRANTED
Monday, February 17, 2014EXTENSION 5 FILED
Monday, February 17, 2014TEAS EXTENSION RECEIVED
Tuesday, August 20, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 19, 2013EXTENSION 4 GRANTED
Wednesday, August 14, 2013EXTENSION 4 FILED
Wednesday, August 14, 2013TEAS EXTENSION RECEIVED
Wednesday, March 20, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, March 20, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, March 15, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, March 15, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, February 20, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 19, 2013EXTENSION 3 GRANTED
Tuesday, February 12, 2013EXTENSION 3 FILED
Tuesday, February 12, 2013TEAS EXTENSION RECEIVED
Thursday, August 30, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 29, 2012EXTENSION 2 GRANTED
Monday, August 27, 2012EXTENSION 2 FILED
Tuesday, August 28, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, August 27, 2012TEAS EXTENSION RECEIVED
Friday, February 10, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 8, 2012EXTENSION 1 GRANTED
Wednesday, February 8, 2012EXTENSION 1 FILED
Wednesday, February 8, 2012TEAS EXTENSION RECEIVED
Tuesday, August 30, 2011NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 5, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 5, 2011PUBLISHED FOR OPPOSITION
Wednesday, June 1, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, June 1, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, May 26, 2011TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, May 26, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, May 16, 2011TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, February 3, 2011REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Friday, July 30, 2010REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Friday, July 30, 2010ASSIGNED TO LIE
Thursday, May 13, 2010TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, January 28, 2010NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, January 28, 2010LETTER OF SUSPENSION E-MAILED
Thursday, January 28, 2010SUSPENSION LETTER WRITTEN
Wednesday, January 27, 2010ASSIGNED TO EXAMINER
Tuesday, October 27, 2009NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, October 26, 2009NEW APPLICATION ENTERED IN TRAM

Related Keywords

idrelim pharmaceutical treatment substances disorders preparations diseases hormonal neurological gastrointestinal ophthalmic